Cargando…
A study protocol for quantitative targeted absolute proteomics (QTAP) by LC-MS/MS: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood–brain barrier in ddY, FVB, and C57BL/6J mice
Proteomics has opened a new horizon in biological sciences. Global proteomic analysis is a promising technology for the discovery of thousands of proteins, post-translational modifications, polymorphisms, and molecular interactions in a variety of biological systems. The activities and roles of the...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691662/ https://www.ncbi.nlm.nih.gov/pubmed/23758935 http://dx.doi.org/10.1186/2045-8118-10-21 |
_version_ | 1782274508556599296 |
---|---|
author | Uchida, Yasuo Tachikawa, Masanori Obuchi, Wataru Hoshi, Yutaro Tomioka, Yusuke Ohtsuki, Sumio Terasaki, Tetsuya |
author_facet | Uchida, Yasuo Tachikawa, Masanori Obuchi, Wataru Hoshi, Yutaro Tomioka, Yusuke Ohtsuki, Sumio Terasaki, Tetsuya |
author_sort | Uchida, Yasuo |
collection | PubMed |
description | Proteomics has opened a new horizon in biological sciences. Global proteomic analysis is a promising technology for the discovery of thousands of proteins, post-translational modifications, polymorphisms, and molecular interactions in a variety of biological systems. The activities and roles of the identified proteins must also be elucidated, but this is complicated by the inability of conventional proteomic methods to yield quantitative information for protein expression. Thus, a variety of biological systems remain “black boxes”. Quantitative targeted absolute proteomics (QTAP) enables the determination of absolute expression levels (mol) of any target protein, including low-abundance functional proteins, such as transporters and receptors. Therefore, QTAP will be useful for understanding the activities and roles of individual proteins and their differences, including normal/disease, human/animal, or in vitro/in vivo. Here, we describe the study protocols and precautions for QTAP experiments including in silico target peptide selection, determination of peptide concentration by amino acid analysis, setup of selected/multiple reaction monitoring (SRM/MRM) analysis in liquid chromatography–tandem mass spectrometry, preparation of protein samples (brain capillaries and plasma membrane fractions) followed by the preparation of peptide samples, simultaneous absolute quantification of target proteins by SRM/MRM analysis, data analysis, and troubleshooting. An application of QTAP in biological sciences was introduced that utilizes data from inter-strain differences in the protein expression levels of transporters, receptors, tight junction proteins and marker proteins at the blood–brain barrier in ddY, FVB, and C57BL/6J mice. Among 18 molecules, 13 (abcb1a/mdr1a/P-gp, abcc4/mrp4, abcg2/bcrp, slc2a1/glut1, slc7a5/lat1, slc16a1/mct1, slc22a8/oat3, insr, lrp1, tfr1, claudin-5, Na(+)/K(+)-ATPase, and γ-gtp) were detected in the isolated brain capillaries, and their protein expression levels were within a range of 0.637-101 fmol/μg protein. The largest difference in the levels between the three strains was 2.2-fold for 13 molecules, although bcrp and mct1 displayed statistically significant differences between C57BL/6J and the other strain(s). Highly sensitive simultaneous absolute quantification achieved by QTAP will increase the usefulness of proteomics in biological sciences and is expected to advance the new research field of pharmacoproteomics (PPx). |
format | Online Article Text |
id | pubmed-3691662 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-36916622013-06-28 A study protocol for quantitative targeted absolute proteomics (QTAP) by LC-MS/MS: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood–brain barrier in ddY, FVB, and C57BL/6J mice Uchida, Yasuo Tachikawa, Masanori Obuchi, Wataru Hoshi, Yutaro Tomioka, Yusuke Ohtsuki, Sumio Terasaki, Tetsuya Fluids Barriers CNS Study Protocol Proteomics has opened a new horizon in biological sciences. Global proteomic analysis is a promising technology for the discovery of thousands of proteins, post-translational modifications, polymorphisms, and molecular interactions in a variety of biological systems. The activities and roles of the identified proteins must also be elucidated, but this is complicated by the inability of conventional proteomic methods to yield quantitative information for protein expression. Thus, a variety of biological systems remain “black boxes”. Quantitative targeted absolute proteomics (QTAP) enables the determination of absolute expression levels (mol) of any target protein, including low-abundance functional proteins, such as transporters and receptors. Therefore, QTAP will be useful for understanding the activities and roles of individual proteins and their differences, including normal/disease, human/animal, or in vitro/in vivo. Here, we describe the study protocols and precautions for QTAP experiments including in silico target peptide selection, determination of peptide concentration by amino acid analysis, setup of selected/multiple reaction monitoring (SRM/MRM) analysis in liquid chromatography–tandem mass spectrometry, preparation of protein samples (brain capillaries and plasma membrane fractions) followed by the preparation of peptide samples, simultaneous absolute quantification of target proteins by SRM/MRM analysis, data analysis, and troubleshooting. An application of QTAP in biological sciences was introduced that utilizes data from inter-strain differences in the protein expression levels of transporters, receptors, tight junction proteins and marker proteins at the blood–brain barrier in ddY, FVB, and C57BL/6J mice. Among 18 molecules, 13 (abcb1a/mdr1a/P-gp, abcc4/mrp4, abcg2/bcrp, slc2a1/glut1, slc7a5/lat1, slc16a1/mct1, slc22a8/oat3, insr, lrp1, tfr1, claudin-5, Na(+)/K(+)-ATPase, and γ-gtp) were detected in the isolated brain capillaries, and their protein expression levels were within a range of 0.637-101 fmol/μg protein. The largest difference in the levels between the three strains was 2.2-fold for 13 molecules, although bcrp and mct1 displayed statistically significant differences between C57BL/6J and the other strain(s). Highly sensitive simultaneous absolute quantification achieved by QTAP will increase the usefulness of proteomics in biological sciences and is expected to advance the new research field of pharmacoproteomics (PPx). BioMed Central 2013-06-08 /pmc/articles/PMC3691662/ /pubmed/23758935 http://dx.doi.org/10.1186/2045-8118-10-21 Text en Copyright © 2013 Uchida et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Study Protocol Uchida, Yasuo Tachikawa, Masanori Obuchi, Wataru Hoshi, Yutaro Tomioka, Yusuke Ohtsuki, Sumio Terasaki, Tetsuya A study protocol for quantitative targeted absolute proteomics (QTAP) by LC-MS/MS: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood–brain barrier in ddY, FVB, and C57BL/6J mice |
title | A study protocol for quantitative targeted absolute proteomics (QTAP) by LC-MS/MS: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood–brain barrier in ddY, FVB, and C57BL/6J mice |
title_full | A study protocol for quantitative targeted absolute proteomics (QTAP) by LC-MS/MS: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood–brain barrier in ddY, FVB, and C57BL/6J mice |
title_fullStr | A study protocol for quantitative targeted absolute proteomics (QTAP) by LC-MS/MS: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood–brain barrier in ddY, FVB, and C57BL/6J mice |
title_full_unstemmed | A study protocol for quantitative targeted absolute proteomics (QTAP) by LC-MS/MS: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood–brain barrier in ddY, FVB, and C57BL/6J mice |
title_short | A study protocol for quantitative targeted absolute proteomics (QTAP) by LC-MS/MS: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood–brain barrier in ddY, FVB, and C57BL/6J mice |
title_sort | study protocol for quantitative targeted absolute proteomics (qtap) by lc-ms/ms: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood–brain barrier in ddy, fvb, and c57bl/6j mice |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691662/ https://www.ncbi.nlm.nih.gov/pubmed/23758935 http://dx.doi.org/10.1186/2045-8118-10-21 |
work_keys_str_mv | AT uchidayasuo astudyprotocolforquantitativetargetedabsoluteproteomicsqtapbylcmsmsapplicationforinterstraindifferencesinproteinexpressionlevelsoftransportersreceptorsclaudin5andmarkerproteinsatthebloodbrainbarrierinddyfvbandc57bl6jmice AT tachikawamasanori astudyprotocolforquantitativetargetedabsoluteproteomicsqtapbylcmsmsapplicationforinterstraindifferencesinproteinexpressionlevelsoftransportersreceptorsclaudin5andmarkerproteinsatthebloodbrainbarrierinddyfvbandc57bl6jmice AT obuchiwataru astudyprotocolforquantitativetargetedabsoluteproteomicsqtapbylcmsmsapplicationforinterstraindifferencesinproteinexpressionlevelsoftransportersreceptorsclaudin5andmarkerproteinsatthebloodbrainbarrierinddyfvbandc57bl6jmice AT hoshiyutaro astudyprotocolforquantitativetargetedabsoluteproteomicsqtapbylcmsmsapplicationforinterstraindifferencesinproteinexpressionlevelsoftransportersreceptorsclaudin5andmarkerproteinsatthebloodbrainbarrierinddyfvbandc57bl6jmice AT tomiokayusuke astudyprotocolforquantitativetargetedabsoluteproteomicsqtapbylcmsmsapplicationforinterstraindifferencesinproteinexpressionlevelsoftransportersreceptorsclaudin5andmarkerproteinsatthebloodbrainbarrierinddyfvbandc57bl6jmice AT ohtsukisumio astudyprotocolforquantitativetargetedabsoluteproteomicsqtapbylcmsmsapplicationforinterstraindifferencesinproteinexpressionlevelsoftransportersreceptorsclaudin5andmarkerproteinsatthebloodbrainbarrierinddyfvbandc57bl6jmice AT terasakitetsuya astudyprotocolforquantitativetargetedabsoluteproteomicsqtapbylcmsmsapplicationforinterstraindifferencesinproteinexpressionlevelsoftransportersreceptorsclaudin5andmarkerproteinsatthebloodbrainbarrierinddyfvbandc57bl6jmice AT uchidayasuo studyprotocolforquantitativetargetedabsoluteproteomicsqtapbylcmsmsapplicationforinterstraindifferencesinproteinexpressionlevelsoftransportersreceptorsclaudin5andmarkerproteinsatthebloodbrainbarrierinddyfvbandc57bl6jmice AT tachikawamasanori studyprotocolforquantitativetargetedabsoluteproteomicsqtapbylcmsmsapplicationforinterstraindifferencesinproteinexpressionlevelsoftransportersreceptorsclaudin5andmarkerproteinsatthebloodbrainbarrierinddyfvbandc57bl6jmice AT obuchiwataru studyprotocolforquantitativetargetedabsoluteproteomicsqtapbylcmsmsapplicationforinterstraindifferencesinproteinexpressionlevelsoftransportersreceptorsclaudin5andmarkerproteinsatthebloodbrainbarrierinddyfvbandc57bl6jmice AT hoshiyutaro studyprotocolforquantitativetargetedabsoluteproteomicsqtapbylcmsmsapplicationforinterstraindifferencesinproteinexpressionlevelsoftransportersreceptorsclaudin5andmarkerproteinsatthebloodbrainbarrierinddyfvbandc57bl6jmice AT tomiokayusuke studyprotocolforquantitativetargetedabsoluteproteomicsqtapbylcmsmsapplicationforinterstraindifferencesinproteinexpressionlevelsoftransportersreceptorsclaudin5andmarkerproteinsatthebloodbrainbarrierinddyfvbandc57bl6jmice AT ohtsukisumio studyprotocolforquantitativetargetedabsoluteproteomicsqtapbylcmsmsapplicationforinterstraindifferencesinproteinexpressionlevelsoftransportersreceptorsclaudin5andmarkerproteinsatthebloodbrainbarrierinddyfvbandc57bl6jmice AT terasakitetsuya studyprotocolforquantitativetargetedabsoluteproteomicsqtapbylcmsmsapplicationforinterstraindifferencesinproteinexpressionlevelsoftransportersreceptorsclaudin5andmarkerproteinsatthebloodbrainbarrierinddyfvbandc57bl6jmice |